SiriusXT

Dublin, Ireland Founded: 2015 • Age: 11 yrs
X-ray technology is used for 3D imaging of biological cells.

About SiriusXT

SiriusXT is a company based in Dublin (Ireland) founded in 2015. SiriusXT has raised $3.33 million across 8 funding rounds from investors including European Union and Emergency Interoperability Consortium. SiriusXT offers products and services including SXT100. SiriusXT operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, IBA, SpectraWAVE and Ionpath, among others.

Key Metrics
  • Total Equity Funding
    $3.33M (USD)

    in 8 rounds

  • Latest Funding Round
    $975.07K (USD), Grant

    Jan 2021

  • Investors

Products & Services of SiriusXT

SiriusXT offers a comprehensive portfolio of products and services, including SXT100.

SXT100
Soft X-Ray Microscope

Enables high-resolution 3D imaging of hydrated cells for research.

Apps and channels of SiriusXT

its YouTube channel SiriusXT has 24 subscribers and 9 videos.

SiriusXT
YouTube 24 subscribers 9 videos Science & Technology
Open channel

Videos from SiriusXT

The most watched videos on SiriusXT's YouTube channel, SiriusXT (24 subscribers). Click a video to play it here.

SXT-100 Cell Imaging Workflow
295 views
SXT-100 - Soft X-Ray Microscope - Video Presentation
230 views
Seeing Cells in 3D: Bringing Soft X-ray Tomography to the Lab - presentation at Euro-Bioimaging 2023
198 views
SXT-100 - Soft X-Ray Microscope
188 views

More on SiriusXT.

Funding Insights of SiriusXT

SiriusXT has successfully raised a total of $3.33M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $975.07 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.33M
  • Total Rounds 8
  • Last Round Grant β€” $975,066
  • First Round $53,650

    (Nov 2015)

  • Investors Count 2

All 8 funding rounds of SiriusXT with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$975,066Grant––
Aug 2020$1.78MGrant––
Jun 2020–Series A–Emergency Interoperability Consortium
–
Mar 2017$185,270Grant––
Jan 2017$183,205Grant––
Jan 2017$3.16MGrant––
Aug 2016$3.33MSeries A––
–
Nov 2015$53,650Grant––
–
Valuation history

2 investors in total: 2 institutional.

Investors in SiriusXT

SiriusXT has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Emergency Interoperability Consortium.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
-
–eic.org-
Premium access

Investor details for SiriusXT

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of SiriusXT

11 people are tracked at SiriusXT (3 in leadership, 8 in team).

NameRoleGroup
Fergal O'Reilly
Chief ScientistLeadership
Sergey Kapishnikov
Director Of Imaging ApplicationsLeadership
Paul Sheridan
Chief Technology OfficerLeadership
Alberto Manzoni
Sr. Software EngineerTeam
Martina Donnellan
Senior Instrumentation ScientistTeam
William Fyans
Engneering ManagerTeam
Fionán Tierney
Senior Design EngineerTeam
Stephen O'Connor
Instrumentation ScientistTeam
Catherine Boothman
Software Developer & Data ScientistTeam
Conal McIntyre
Instrument ScientistTeam
Síofra Ní Lochlainn
Mechanical Design EngineerTeam
Premium access

Complete people profiles for SiriusXT

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of SiriusXT

3 dated milestones of SiriusXT across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded SiriusXT is founded.
  2. Funding First funding round of $54K.
  3. Funding Latest funding round, Grant, of $975K.

Competitors of SiriusXT

SiriusXT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, IBA, SpectraWAVE and Ionpath, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
oxinst.com1959Abingdon, United Kingdom–2,027
Technology tools and systems for molecular scale are developed.
leica-microsystems.com1914Wetzlar, Germany–67
Imaging solutions for macro, micro, and nano structures are provided.
iba-worldwide.com1986–$27.32M–
Innovative solutions for cancer treatment and industrial applications are provided by IBA.
spectrawave.com2012Waltham, United States$79.88M36
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
ionpath.com2014Menlo Park, United States$18M37
Multiplexed ion beam imaging platform for tissue biopsies is developed.
invenio-imaging.com2012Santa Clara, United States$7.5M–
Provider of a tissue imagine software and hardware solution for research diagnosis
chromacitylasers.com2013Edinburgh, United Kingdom$4.93M12
Tunable fiber lasers are provided for industrial and scientific applications.
lynceantech.com2002Fremont, United States$26.91M39
Delivers advanced imaging systems using local synchrotron x-ray sources for scientific and industrial applications.
kfbio.cn2011Yuyao, China$28.98M–
Digital pathology systems are developed for image analysis and diagnosis.
Premium access

Detailed competitors of SiriusXT

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of SiriusXT

The website of SiriusXT (siriusxt.com) receives about 2.4K visits a month.

  • Monthly visits
    2.4K

    ▼ 12.7% vs previous month

Latest news on Siriusxt

Premium access

Complete news archive for SiriusXT

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to SiriusXT

10 companies that operate in the same segment as SiriusXT (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SiriusXT

SiriusXT was founded in 2015.

SiriusXT is headquartered in Dublin, Ireland.

SiriusXT is a funded company, having raised a total of $3.33M across 8 funding rounds to date. The company's 1st funding round was a Grant of $53.65K, raised on Nov 2015.

SiriusXT was founded in 2015 in Dublin, Ireland, within the life sciences sector. X-ray based solutions for 3D imaging of biological cells are developed by the company. A proprietary SXT system, functioning as a soft X-ray microscope with vacuum-based laser-produced plasma sources, is offered as a benchtop instrument. Cells are imaged in their native, fully hydrated state. Customers encompass biopharma firms, diagnostics entities, and life science researchers.

SiriusXT's top competitors include Oxford Instruments, Leica Microsystems and IBA.

SiriusXT offers SXT100.

SiriusXT has 2 investors. Key investors include European Union, and Emergency Interoperability Consortium.

SiriusXT operates through Siriusxt Ltd..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available